Clinical Trials Directory

Trials / Unknown

UnknownNCT05047159

The Role of Neuromodulation Technique In Depression Disorder

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
450 (estimated)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study aims to explore the efficacy, safety and long-term effects of common and available non-invasive neuromodulation techniques in the treatment of depression, and to provide a data basis for the establishment of individualized treatment and efficacy prediction models. 450 patients will be enrolled and randomly assigned to five different treatments. Psychopathological assessment will be performed in both acute and maintenance phases of treatment with the Hamilton Depression Rating Scale, the Hamilton Anxiety Rating Scale, and the Patient Health Questionaire-9, the Sheehan Disability Scale, the Vascular Quality of Life-6 Questionnaire respectively.

Conditions

Interventions

TypeNameDescription
DEVICErTMSStimulation will be performed for 20 working days once a day (4 weeks). Extend course to 30 sessions (6 weeks) in responders who have not achieved symptom remission. Frequency: 10Hz; Intensity: 110% RMT; Coil-type: F8; Sessions-pulse: 3000; Site: the left dorsolateral prefrontal cortex.
DEVICElight therapyActive 10,000-lux fluorescent white light box for 30 min/d in the early morning for 6 weeks.
DEVICEECTThe electrode placements are bifrontal (BF); the electrical intensity is 1.5 to 2.0 times the seizure threshold (ST); 3 times per week.
DEVICEMSTA coil placement at the vertex (i.e., Cz in 10-20 electroencephalogram \[EEG\] system) with a frequency of stimulation of 100 Hz, pulse width of 0.2 to 0.4 ms, and stimulation duration of 10 seconds; 2 times per week.
DRUGdrug therapyThere is no restriction on the choice of therapeutic drugs.

Timeline

Start date
2022-11-01
Primary completion
2024-03-30
Completion
2024-06-30
First posted
2021-09-16
Last updated
2022-10-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05047159. Inclusion in this directory is not an endorsement.